Growth Boosting Dynamics:

Increasing uptake of biopharmaceutical drugs is expected to drive the pharmaceutical excipients market growth. Biopharmaceuticals are gradually becoming popular in the healthcare industry due to their similarity to natural biological compounds found in the human body; thus, they offer high efficacy and fewer side-effects. They form one of the…

Major Growth Boosting Factors:

The growth of Healthcare IT market is majorly attributed to government mandates & support for healthcare IT solutions; rising use of big data in healthcare; high returns on investment associated with healthcare IT solutions; the need to curtail escalating healthcare costs; the growing demand for and use of HCIT solutions due to COVID-19; and the growing mHealth, telehealth, and remote patient monitoring markets. On the other hand, IT infrastructural…

Major Industry Growth Driving Factors:

Growth in the pharmaceutical drug delivery market can largely be attributed to factors such as the rising prevalence of chronic diseases, growing biologics market, increasing R&D investments, and technological advancements & new product launches.

On the other hand, the risk of needlestick injuries and the increased pricing pressure is expected to limit the market growth to some extent in the coming years.

Expected Revenue…

Global Growth:

Growth of the global stem cell banking market is primarily driven by growing public awareness related to the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing, and storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increasing stem cell-based research.

On the other hand, the high operational costs associated with stem cell banking and stringent regulatory frameworks are…

Drug delivery technologies improve the efficacy and safety of a drug by controlling the rate, time, and place of drug release in the body. This market is highly competitive and is witnessing rapid growth due to the development of numerous new routes of drug delivery.

The global pharmaceutical industry is research-intensive, with innovative firms spending on average about 15% of their sales on R&D. Also, the increasing R&D expenditure on early-stage development, as well as an…

Increasing uptake of biopharmaceutical drugs is expected to drive the market growth. Biopharmaceuticals are gradually becoming popular in the healthcare industry due to their similarity to natural biological compounds found in the human body; thus, they offer high efficacy and fewer side-effects.

They form one of the fastest-growing segments of the pharmaceutical industry. Novel concepts like cell therapy (for cancer treatment) and gene therapy (offering regenerative medicine) are…

Overview of This Study:

The study involved four major activities in estimating the current size of the ENT Devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary…

Opportunity: Delivery of biologics through the transdermal route

The delivery of biologics through the transdermal route is one of the emerging trends in the topical drug delivery market. The transdermal delivery of large molecules as an alternative to intramuscular, subcutaneous, or intravenous routes of administration is expected to provide significant patient benefits, such as painless drug delivery and cost-effective treatment.

Challenge: Technical barriers related to skin…

Healthcare cloud computing Market Dynamics

Drivers: Growing adoption of EHR, e-prescribing, telehealth, mHealth, and other healthcare IT solutions due to COVID-19

Globally, the prevalence of chronic diseases, such as cancer, CVD, and diabetes, has increased significantly over the last few decades. According to the WHO (2016), CVD is the leading cause of…

Drug delivery is the method or process of administration of a pharmaceutical drug to safely attain its desired therapeutic effect. Advancements in drug delivery technologies offer several benefits, such as ease of use, convenience, and patient compliance. Drug developers are focusing on suitable delivery and packaging options for increasing the efficiency of drugs and proposing improved patient compliance.

Pharmaceutical and biopharmaceutical companies are focusing on R&D to…

Major Growth Influencing Factors:

The Healthcare Cloud Computing Market is primarily driven by factors such as the growing adoption of EHR, e-prescribing, telehealth, mHealth, and other healthcare IT solutions due to COVID-19; the increasing adoption of big data analytics, wearable devices, & IoT; increasing cloud deployment in the healthcare industry; better…

Overview of This Study:

This study involved four major activities in estimating the current size of the active pharmaceutical ingredient market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value…

Major Growth Driving Factors:

The growing target patient population, ongoing product development, and commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across the emerging markets, growth in market demand for effective neurovascular devices, increase in research in the field of neurovascular therapies, rise in demand for minimally invasive neurosurgical procedures, and increase in awareness among neurosurgeons about minimally invasive surgical…

Major Growth Influencing Factors:

The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development & development of human microbiome-based tests for early disease detection and diagnosis are also factors expected to support market growth.

Increasing collaborations between private-public organizations are expected to provide significant growth…

Major Growth Boosting Factors:

Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism, growing dental tourism, rising incidences of dental caries and other periodontal diseases and increasing outsourcing of certain manufacturing functions to dental laboratories are the factors contributing to the growth of this Dental Lab…

Overview:

This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global clinical trial supplies market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to…

The global intraoperative imaging market size is estimated to be USD 1.9 billion in 2020 and projected to reach USD 2.5 billion by 2025, at a CAGR of 5.2 %. Increasing prevalence of diseases and disorders, technological advancements and increased funding and public-private investments are the key factors driving the growth of the intraoperative imaging.

The intraoperative imaging market includes major Tier I and II suppliers like General Electric Company (US), Siemens…

The transdermal drug delivery systems market is projected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period of 2018 to 2023. Market growth is largely driven by the global increase in the prevalence of chronic diseases. In addition, technological advancements in transdermal drug delivery systems are also expected to support market growth in the coming years.

Global Leading…

The global human organoids market size is estimated to be USD 850 million in 2020 and projected to reach USD 1,901 million by 2025, at a CAGR of 17.5%. Increasing prevalence of transplantation, technological advancements and increased funding and public-private investments are the key factors driving the growth of the human organoids.

The human organoids market includes major Tier I and II suppliers like BioIVT (US), Thermo Fisher Scientific (US), ZenBio (US),…

Overview of This Study:

The study involved two major activities in estimating the current market size of the fill-finish manufacturing market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. After that, market breakdown and data triangulation were used to estimate the…